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Abstract
Ongoing evaluation of current practice and incorporation of evidence based research into
guidelines and protocols is a requirement for the provision of high quality, cost efficient care.
Despite some literature describing observational data, midline catheters (MCs) are not an
appropriate vascular access device for Newborn Intensive Care Unit (NICU) patients due to
insufficient high level evidence demonstrating safety and efficacy. In addition, national
guidelines for MC use in neonatal and infant patients lacks sufficient information for safe and
effective use of MCs.
The results of this small, online survey indicate that while some neonatal nurses and
Nurse Practitioners report the use of MC use in the NICU, there is a wide range of practice
pertaining to MC unit-specific protocols, competencies, success with placement, and clinician
agreement of appropriate use for this vascular access device (VAD). Multicenter, randomized
control trials are needed to evaluate current MC practice in the NICU, and institutions must
incorporates current, evidence based practice into policies, procedures, and guidelines.

Keywords: catheters, infant, midline, neonatal, and premature

Introduction
Prolonged intravenous (IV) access is frequently required for critically ill and premature
infants in the Newborn Intensive Care Unit (NICU) to provide nutritional and pharmacologic
support. High level evidence must guide clinical decision making and management of all
vascular access devices (VADs), including peripheral intravenous (PIV) catheters, peripherally
inserted central catheters (PICCs), and midline catheters (MCs). Institutional and national PICC
guidelines include basic MC information, but VAD decision making may be based on clinician
preference rather than clinical evidence due to a lack of evidence based research in the form of
high quality studies (National Association of Neonatal Nurses PICC Guidelines, 2007). When
deciding upon which VADs are appropriate for individual patients, the NICU team may have
difficulty reaching consensus based on professional experience and/or lack of knowledge
regarding evidence based recommendations.
Prospective observational studies have demonstrated that when compared to peripheral
IVs, MCs result in fewer cannulations, longer dwell times, less extravasation, and improved cost
efficiency (Alexandrou et al., 2011; Anderson, 2004; Dawson, 2002; Frey & Pettit, 2010; Goetz,
Miller, Wagener, & Muder 1998.; Griffiths, 2007; Leick-Rude and Haney, 2006; Lesser,
Chhabra, Brion, & Suresh, 1996; National Association of Neonatal Nurses, 2007; Rosenthal,
2008; Victor, 1997; and Wyckoff, 1999). When compared to PICCs, prospective observational
studies found MCs to have increased rates of chemical and mechanical phlebitis and lower rates
of infection (Alexandrou et al., 2011; Colacchio, Deng, Northrup, & Bizzarro, 2012; Goetz, et
al., 1998; Leick-Rude and Haney, 2006; Lesser et al., 1996; NANN, 2007; Victor, 1997).
Several authors have reported that MCs may also improve cost efficiency by minimizing the time
and equipment spent on repeated PIV cannulations (Alexandrou, et al., 2011; Anderson, 2004;
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Griffiths, 2007; and Rosenthal, 2008). Dawson (2002) found that the potential for cost savings
may result from fewer central line infections and shorter length of hospital stay, less nursing time
required, and lower pharmacological costs. Unfortunately, there is a lack of evidence in the form
of randomized control trials or systematic reviews, to support the observational findings
suggesting that MCs may be a safe and reliable VAD for NICU patients.
Problem
As clinicians strive to improve health care in the information age of the 21st century, it is
crucial that clinicians not only recognize, but accept and integrate evidence-based practice (EBP)
into patient care on a daily basis. Rapidly advancing technology, an aging population, and
increasingly complex medical diagnoses, challenge health care professionals to maintain a
current knowledge base and to provide care that is proven to be effective, safe, and cost efficient.
Integration of EBP is a steadfast requirement for clinical decision-making and for providing
standardized care for patients across all settings. According to Grol and Grimshaw (2005),
approximately 10,000 new randomized trials are added to MEDLINE every year. It is difficult
for clinicians to synthesize the continual high volume of published evidence, and even more
challenging to incorporate changes in clinical practice into daily patient management. As a
result, there is a known gap between clinical evidence and clinical practice across disciplines.
Prasad et al. (2013) found that of 35 studies testing standard of care, 46% contradicted current
practice. In fact, studies suggest that 30-40% of patients do not receive care according to current
scientific evidence (Grol & Grimhaw, 2005).
Another barrier to implementing current clinical evidence into daily clinical practice may
reside in the dependence on clinical practice guidelines which are lacking in evidence based
recommendations. Clinical practice guidelines are typically developed by professional
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organizations and provide a foundation for state and institutional protocols. Unfortunately,
guidelines and protocols may not be based on the most current evidence, and there is increasing
concern about the quality of guidelines produced by national organizations (Cosgrove, Bursztajn,
Erlich, Wheeler, & Shaughnessy, 2012; Singleton & Levin, 2008). As such, the quality of
clinical practice guidelines may be variable and may not incorporate evidence based research
into recommendations for standard of care. (Brouwers et al., 2010).
Silverman (2004) adeptly described the history and evolution of oxygen use in premature
infants, beginning in the 1940s. The lack of evidence for the use of oxygen necessitated multiple
attempts to guide the use of this unfamiliar “drug” and address the subsequent epidemic of
blindness that followed. Guidelines for the use of oxygen in premature infants continues to
evolve and elicit ongoing research today. Makic, Martin, Burns, Philbrick, & Rauen (2013)
discuss the recognized problem of care being guided by tradition rather than current evidence.
Implementation of a change in clinical practice guidelines may be another obstacle in the effort
to improve patient care based on current high level evidence. In order to successfully implement
a change in guidelines and protocols, it is important to acknowledge the potential for doubt about
the need for innovation (van Achterberg, Schoonhoven, & Grol, 2008).
Solution
According to Raines (2013), EBP is “the conscientious, explicit, and judicious use of
current research findings.” It is the “integration of individual clinical expertise with the best
available external clinical evidence from systematic research” (p. 203). The importance of EBP
is recognized by health care companies, government agencies, and national professional
organizations (Makic, et al., 2013). When the highest quality of clinical research is completed, it
then becomes the responsibility of multidisciplinary teams to synthesize the evidence and
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incorporate the findings into clinical practice guidelines and protocols. The AGREE II tool was
developed to “assess the quality of guidelines; provide a methodological strategy for the
development of guidelines; and to inform what information and how information ought to be
reported in guidelines” (Brouwers et al., 2010, p. 1).
The solution, then, lies in scrutinizing national, state, and institutional guidelines and
protocols for inclusion of the most current and evidence based research. According to the
Institute of Medicine (2011), clinical practice guidelines should provide an evaluation of current
evidence based research in such a way as to enable clinicians to provide the highest quality of
standardized care. If a change in clinical practice if indicated, the process for change must be
implemented in such a way that allows for an understanding of the importance and necessity of
EBP, and provides an opportunity for clinicians to embrace the need for innovation.
Project Purpose
According to the National Association of Neonatal Nurses (NANN) PICC Guidelines,
establishing uninterrupted therapy, preserving the peripheral vasculature, cost efficiency, and
patient comfort should be taken into consideration when deciding which VAD is most
appropriate (2007). Limited data is available on MCs in the NICU and all available research is
strictly observational (Anderson, 2004; BeVier & Rice, 1994; Goetz, et al., 1998; and Griffiths,
2007; Leick-Rude & Haney, 2006; Lesser et al., 1996; Mermel, Parenteau, & Tow, 1995;
Wyckoff, 1999).
Ongoing evaluation of current practice and incorporation of current, evidence based
research into guidelines and protocols is a requirement for the provision of high quality, cost
efficient care. The use of MCs in the NICU is not supported by high level evidence. The project
purpose is to provide for a diffusion of knowledge, via scholarly review and clinician education,

5
in such a way as to encourage understanding and support for the discontinuation of MC use in
NICU patients, and subsequent change in an institutional protocol.
Rogers’ theory for diffusion (2003) is applicable in the effort to implement change as the
four main elements for changing MC use will involve diffusion, innovation, communication, and
the social system of the NICU. Furthermore, as described by van Achterberg et al. (2008),
activities to guide change may be involuntary, such as official changes to guidelines and
protocols; or voluntary, such as when educational efforts and clinical support result in extrinsic
and intrinsic motivation. The project will incorporate Rogers’ theory for diffusion while
encouraging multidisciplinary motivation for what will ultimately be a change in clinical practice
as MCs become discontinued as a viable VAD for use in NICU patients.
In accordance with the American Association of Colleges of Nursing Essentials of
Doctoral Education for Advanced Practice (2006), several objectives for graduate learning
outcomes are realized by a thorough review of the literature, evaluation of current policies and
procedures, and analysis of current trends in clinical decision making regarding the use of MCs
in the NICU. Competent leadership skills are required to successfully institute a feasible and
sustainable change in practice as a result of diffusion of knowledge based on a lack of high level
evidence for the use of MCs in the NICU.
Definition of Terms
Midline catheter (MC). The MC is a peripheral vascular access device with the tip
terminating in the basilic, cephalic, or brachial vein (Infusion Nursing Society, 2011).
According to Frey and Pettit (2010):
The midline catheter, composed of polyurethane or silicone, is longer than a peripheral
IV catheter and is intended for use in neonates and children who require therapy of
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intermediate duration. The catheter is inserted into a peripheral vein in the antecubital
area and is advanced into the upper arm veins, but not past the axilla. Other sites for
midline insertion include the leg (with the tip away from areas of flexion and below the
groin) and the scalp (with the tip located in the neck and above the thorax).
Neonate. A newborn infant, in the first 28 days of life (Dictionary.com).
Peripherally inserted central catheter (PICC). The NANN PICC Guidelines define a
PICC as a “device inserted into a peripheral vein and threaded into the central venous
circulation” (p. 6).
Peripherally inserted non-central catheter (PINCC). According to Colacchio, et al.
(2012), PINCCs are intended to be centrally located as a PICC, but do not reach a central
position during the procedure. MCs are different from PINCCs as the catheters are shorter and
they are not intended to be placed centrally.
Peripheral intravenous catheter (PIV). The tip of a PIV terminates in a peripheral vein.
Premature infant. An infant born at any date during pregnancy prior to the completion
of 37 weeks gestation (Merenstein & Gardner, 1993).
Summary
To date, there are no randomized control trials or systematic reviews examining the use
of MCs in the neonatal population. However, observational studies support the use of MCs for
the infusion of IV fluids and medications in infants who meet criteria based on expected dwell
time, infusate composition, and certain physiologic requirements. Professional experience
and/or lack of knowledge may result in disagreement among clinical providers in regard to VAD
decision making in the neonatal population.
Review of Literature
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A PICO (i.e. Population, Intervention, Comparison, and Outcome) question was used to
guide the literature review (Melnyk, Fineout-Overholt, Stillwell, & Williamson, 2010). The
PICO question is: In the NICU, how is the incidence of infection and extravasation associated
with VADs affected by the implementation of a MC Protocol? The population in this review is
sick and premature neonates and infants in the NICU; the intervention is the development and
implementation of an NICU MC Protocol; the comparison group is the group of infants who
receive MCs based on protocol criteria; and the outcomes are the rates of PICC and MC related
infection and extravasation after the MC Protocol is incorporated into the IV access algorithm.
Data Sources and Search Process
The keywords utilized in the search included catheters, infant, midline, neonatal, and
premature. The databases utilized in the search were CINAHL, Cochrane Library, Joanna
Briggs Institute, Ovid Medline, and Pubmed. Twenty-six publications were identified by
database and hand searches. Eleven publications remained after duplicates were removed. Four
publications were eliminated because they contained content about central lines (PICCs or
umbilical lines) exclusively, and/or the VADs being reviewed were not clearly defined as central
or midline. In addition to journal articles, the hand search included the Infusion Nurses (INS)
Society Position Paper on (1997), the INS Standards of Practice publication and textbook (2011),
and the NANN PICC Guidelines (2007). A total of 18 publications were included for the
literature review (Figure 1). See Appendix A for Tables 1, 2, and 3 which provide a synopsis of
the literature review.

15 Publications identified using database search:
• 4 CINAHL
• 0 Cochrane Library
• 2 Joanna Briggs Institute
• 6 Medline
• 3 PubMed

Excluded (n = 4)
Reason: content exclusive to central
lines only, or catheters were not
clearly defined as central or midline

Screening

Identification
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Eligibility

Database search results combined
after duplicates removed
(n = 11)

Included

Hand search results
(n = 11)

Included for manuscript
review (n = 18)

Figure 1. Flow diagram of publication selection process. Adapted from “Reprint - Preferred
reporting items for systematic reviews and meta-analyses: The PRISMA statement,” by D.
Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and The PRISMA Group, 2009, Physical Therapy,
89(9).
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Evaluation of Clinical Practice Guidelines
The original Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument
was published in 2003 to assess the quality of clinical practice guidelines. The AGREE II
Instrument replaced the original AGREE Instrument in 2010. In addition to the quality of
guidelines, the AGREE II also assesses the “methodological rigor and transparency” of clinical
guidelines development (Brouwers et al., 2010). The AGREE II Instrument includes 23 items
which are organized into six domains: scope and purpose, stakeholder involvement, rigor of
development, clarity of presentation, applicability, and editorial independence. The NANN
PICC Guideline for Practice, 2nd Edition (2007) was evaluated by the AGREEII Instrument (see
Appendix B).
Scope and practice. The intent of the guidelines, as stated in the preface, is to support
nursing practice and promote infant safety in regard to insertion and maintenance of PICCs in
neonatal patients. The content of the guidelines includes a section on Potential Insertion-Related
Difficulties and a troubleshooting guide to address clinical issues. Although the guideline is
intended for infants, there is no mention of specific recommendations for gestational age, postconceptual age, or weight.
Stakeholder involvement. The acknowledgments, state that BD Medical Systems
provided an educational grant for the publication of the guideline. The authors and reviewers are
also acknowledged. The target population perspective is addressed by the inclusion of a parent
information guide in the appendix. Target users of the guideline are nurses trained in neonatal
PICC insertion and maintenance.
Rigor of development. The guideline is most negligent in this domain as there is no
mention of a systematic review of the literature or how evidence was selected for development of
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the recommendations. A thorough reference section is included. The risks associated with PICC
placement in the neonatal population are included in a section on Post-insertion Complications.
The translation of evidence into practice recommendations is available in an appendix as Clinical
Competencies. A list of external nursing reviewers is included in the acknowledgment section.
Clarity of presentation. Procedural guidelines for PICC placement are clear and
specific. Midline catheter procedure guidelines are not included. VAD comparisons and
infusate considerations are reviewed. Due to limited data on recommended dwell times for
midline catheters, and variations in diagnosis, vascular assessment, and therapeutic and
nutritional needs among NICU patients, an algorithm of recommended VAD decision making is
not included.
Applicability. Other than a brief discussion of Food and Drug Administration reporting
requirements for device malfunctions, there is no discussion of barriers, guideline utilizations, or
quality indicators. Educational competencies, vein anatomy figures, a trouble-shooting guide,
and documentation tools are included in the guidelines. Applicable cost-related issues are not
included. Measurements of guideline recommendation outcomes are not included.
Editorial independence. The Acknowledgment section includes a statement declaring
that although BD Medical provided a grant for the guideline development, they had no input into
the content of the guideline. The developing group does not appear to have competing interests.
Overall Guideline Assessment. An evaluation of NANN’s PICC Guidelines for
Practice with the AGREE II tool, resulted in a score of 39%, with the highest possible score
being 100% (Appendix A). The Rigor of Development and Applicability domains were scored
the lowest. This clinical guideline for practice is recommended for use with modifications.
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Analysis
Historical perspective. Midline catheters were first introduced in the adult population in
the 1950s by Deseret Medical Corporation. The device was inserted by an introducer needle and
was used for surgical patients requiring at least seven days of IV therapy (Anderson, 2004;
Griffiths, 2007). The design of the midline catheter continued to evolve and a peel-away plastic
introducer was developed in the 1980s. In 1992, Moran described a new midline catheter being
used in the neonatal population. The Aquavene Catheter, manufactured by Landmark, did not
entail an introducer or a guidewire, and was inserted by an over-the-needle design. At that time
the Landmark catheter was felt to be advantageous, particularly for neonatal patients because the
biocompatible polymer, Aquavene, reportedly softened to become flexible and expand in the
vessel. This feature demonstrated dwell times comparable to silicone catheters, but with less risk
for infection. The catheters were also felt to be less thrombogenic due to the hydrogel
component (Alexandrou, et al., 2011; Goetz, et al.; Mermel, et al., 1995; Moran, 1992) .
Although more than 500,000 Landmark catheters had been sold by 1995, there was no
published data available in which the catheters were cultured at the time of removal (Mermel et
al., 1995). This lack of data was the basis for a prospective study by Mermel et al. in 1995,
which evaluated the risk for infection associated with the use of the Landmark catheter in
hospitalized patients. The findings confirmed a low risk for infections related to midline
catheters, but it also became evident that the Landmark catheters had been associated with
several life threatening adverse reactions. The authors described the adverse reactions associated
with catheter placement in three patients and also found several similar unpublished cases which
had been reported to the FDA. Based on concerns that the coating on the Landmark catheter was
the cause of the adverse reactions, it was taken off the market in in 1997 (Anderson, 2004).
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Device. MCs currently available for use in infants are composed of polyurethane or
silicone as single or double lumen, and are available in 1.9-3.0 Fr., and in gauge sizes of 22-24
(Frey & Pettit, 2010; Infusion Nurses Society, 2011).
Placement. Alexandrou, et al. (2011) reported that MCs are not appropriate for adult
patients with a history of thrombosis, hypercoagulopathy, medical conditions which impede
venous flow from an extremity, or those with an arteriovenous fistula for dialysis. Variables to
consider when evaluating which VADs are appropriate for infants including gestational age,
weight, presence of congenital anomalies, cardiorespiratory monitoring requirements, sepsis,
current clinical condition and ability to tolerate the procedure, anticipated type and duration of
IV solutions and medications, previous history with VADs, and the expected duration of IV
therapy (Moran, 1992; NANN, 2007).
Midline catheters are inserted into a peripheral vein in the antecubital fossa and
advanced with the tip terminating in the basilic, cephalic, or brachial vein distal to the shoulder
(Figure 2). According to the Infusion Nurses Society (1997, 2011) additional sites for
consideration in infants include the external jugular, axillary, long and short saphenous,
temporal, and posterior auricular veins (Frey and Petit, 2010; Wyckoff, 1999). In comparison to
PICCs, the tip purposefully does not extend past the axillary vein or the inguinal fold (Colacchio
et al., 2012).
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Courtesy and © Becton, Dickinson and Company
Reprinted with permission

Figure 2. The major veins that may be used for PICC placement in young infants. From National
Association of Neonatal Nurses. (2007). Peripherally inserted central catheters:
Guideline for practice (2nd ed.) (p. 13). Glenview, IL: National Association of Neonatal
Nurses. Reprinted with permission.
MC placement does not require radiologic confirmation as the tip lies in a large,
peripheral vessel (Alexandrou, et al., 2011; Goetz et al., 1998; Griffiths, 2007). As a result of
fewer X-rays with MC placement, Mermel et al. (1995) and Wyckoff (1999) reported reduced
hospital costs. The Intravenous Nurses Society 1997 Position Paper on Midline and
Midclavicular Catheters recommended X-ray confirmation only in the following clinical
situations:
difficulty with catheter advancement; pain or discomfort after catheter advancement;
inability to obtain free flowing blood return; inability to flush the catheter easily; the
guidewire is difficult to remove or is bent after removal; pain, discomfort, feelings of
fullness or coldness, or hearing gurgling sounds during flushing. (p. 177)
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Dwell time. There is a recognized lack of consistent recommendations in the literature
regarding acceptable MC dwell times. Lesser et al. (1996) enrolled nine infants less than 34
weeks’ gestation and greater than five days of age if they were expected to require IV therapy for
at least 10 days. The average dwell time for nine MCs was 9.0 ± 1.4 days and for 23 PIVs, the
average dwell time was 3.1 ± 0.5 days.
In 1999, Wyckoff reported on dwell times for 135 MCs placed in infants less than 30
days old, ranging from 25 weeks to 46 weeks gestation, and ranging in weight from 540 grams to
4010 grams. The mean dwell time for these catheters was 10 days, with a range of one to 80
days. This data was compared to average PIV dwell times of approximately 27.5 to 49.5 hours.
In 2002, Dawson completed a retrospective chart review of 32 infants who received MCs.
A unit protocol for this review included a requirement for MCs to be placed at the time of
admission for all neonates expected to require a minimum of three days of IV therapy. The
gestational age of the infants who received MCs ranged from 24 to 42 weeks. This data was
compared to other infants of similar gestational age who received PIVs instead of MCs. The
findings revealed that the infants with PIVs experienced an average dwell time of eight days,
with approximately nine venipuncture attempts per day. The MC group of infants experienced
an average dwell time of 6.3 days, with approximately 2.0 venipuncture attempts per day.
Leick-Rude and Haney (2006) conducted a prospective quality assurance monitoring
review of 1,130 MCs placed in 858 infants of gestational ages 23 to 42 weeks, weighing 3608,000 grams. The MCs were inserted when the infants were 23-61 days of age. The scalp was
the most frequently used site, with an average dwell time of 9.2-10 days. MCs placed in the
scalp were discontinued electively more than any other site, had the least number of infiltrations
(17%), and 19% were removed for occlusion. Upper extremity MCs were removed due to
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infiltration 21% of the time and occlusion 12% of the time. Average dwell time for upper
extremity MCs was 8.1 days. Lower extremity MCs were the least common site used. Average
dwell time for knee insertion was 12.9 days and for ankle insertion was 7 days.
Leick-Rude and Haney (2006) reported that 22% of the MCs were removed for
infiltration, 17% for occlusion, 11% for leaking, 4% for dislodgement, 2% for phlebitis, and two
MCs were removed for malposition based on clinical presentation. There were 39 blood cultures
obtained from the infants while a MC was in place and 8 MCs were removed because of a
positive blood culture. Sixty-one percent of the infants with positive blood cultures also had a
central line in place when the culture was drawn. Of the infants with positive blood cultures,
1.3% had only a MC.
Some authors suggest the feasibility of choosing a MC for a patient is based on an
expected need for IV therapy greater than seven days (Goetz et al., 1998). Griffiths (2007)
reports that Vygon, a company which makes MCs, recommends that dwell times be based on the
expected duration of treatment, rather than on a specified time scale. The INS recommends
consideration for MC placement in neonates when IV therapy is expected to last 1-4 weeks. The
NANN recognize that mean MC dwell times are typically reported to be between six to 10 days,
but acknowledges the fact that current data does not exist to support a limit to the dwell time of
properly functioning MCs.
Cost. MC use in the NICU may result in cost savings associated with lower infection
rates, less nursing time required due to fewer venipunctures, less pharmacy costs for antibiotics,
and ultimately a shorter length of stay (Alexandrou et al., 2011; Dawson, 2002; Joanna Briggs
Institute, 1998; Lesser et al., 1996; Rosenthal, 2008). When compared to PIVs, MCs are
typically more cost efficient in patients who meet criteria for placement (Anderson, 2004).

16
According to the NANN PICC Guidelines, the cost of a MC is equivalent to that of a PIV after 34 days of therapy. In patients who are clinically appropriate for home IV therapy, MCs are more
cost effective than PICCs as a result of the ability to allow for an earlier discharge home
(Griffiths, 2007). In comparison to PICCs, MC placement may also result in cost savings as they
do not require an X-ray to confirm the location of the catheter’s tip (Mermel et al., 1995;
Wychoff, 1999).
Practice criteria. MCs are recommended for solutions with a maximum dextrose
concentration of 10% and isotonic solutions with a pH range of 5 to 9 (Alexandrou et al., 2011;
Griffiths, 2007; Leick-Rude and Haney, 2006; NANN, 2007; Rosenthal, 2008). The INS (2011)
and NANN (2007) recommend infusion of fluid and medications with osmolalities <600
mOsm/kg for MCs. Examples of vesicants and hyperosmolar medications and IV fluids which
are not considered safe for infusion through MCs include Total Parenteral Nutrition with
dextrose concentration of D12.5% or greater, Amphoteracin B, Calcium, chemotherapy
medications, Dilantin, vasopressors, and Vancomycin (NANN, 2007; Rosenthal, 2008).
Summary
There are few studies evaluating MC outcomes, particularly in the pediatric and neonatal
population (Anderson, 2004). In comparison to the multitude of high level research available on
PICCs, there is an absence of randomized control trials and systematic reviews evaluating MCs .
Larger, prospective studies are needed to evaluate current MC practice in the NICU, and the
rates of infection and extravasation associated with their use (Mermel et al., 1995; Victor, 1997).
The INS (1997, 2011) recommends that institutions establish outcome data on specific patient
populations for each VAD, and incorporate evidence based practice into current policies,
procedures, and guidelines. Despite some literature describing observational data, midline
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catheters are not an appropriate vascular access device for NICU patients due to insufficient high
level evidence demonstrating safety and efficacy.
Project Methodology
University of North Florida Institutional Review Board Attachment B for Protocol #
558281-2 is included as Appendix B. This document describes the Participant Population, Study
Procedures and Materials, Risk/Benefit Analysis, and Data and Safety Monitoring, for the
project entitled “Midline Catheter Use in the Newborn Intensive Care Unit: Current Practice
Inquiry”.
Results
A 22 question survey was available for 30 days (as allowed by NANN) on the NANN
website for members to voluntarily complete. The Survey Objectives are included as Appendix
E. NANN reports a membership of 7500 which includes neonatal nurses and Neonatal Nurse
Practitioners. The survey was created and the data was compiled via Qualtrics software. Thirty
six surveys were completed.
Demographics
NICUs are designated as Level 1, 2, 3, or 4 depending on the level of care they are able to
provide for neonates and infants. Level 1 typically equates to a Newborn Nursery with healthy
newborns, and Level 2 for clinically stable infants weighing greater than 1000 grams at birth.
Level 3 NICUs provide most surgical and consultative services for critically ill infants. Level 4
NICUs additionally offer Extracorporeal Membrane Oxygenation, or ECMO, for the sickest of
infants. Seventy-six percent (28) of respondents completing the survey reported working in a
Level 3 NICU.
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Eighty-six percent of participants reported that they work in a NICU and Figure 3
describes participant level of nursing education. The remaining 14% (5) reported their places of
employment as the Newborn Nursery, the Pediatric Intensive Care Unit, and/or Newborn
Transport Teams.

* Other = BSN, CNS, DNP
Figure 3. Education
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Procedure Guidelines, Protocols, and Training (Figures 4-8)

specific MC Protocol in place for neonates and infants.

Figure 4. Procedure Guidelines

Figure 5. Procedure Protocols
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F

Figure 6. PICC Training

Figure 7. MC Training
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Figure 8. VAD Competencies

Participant Estimation of Successful VAD Placement and Usage (Figure 9)

Figure 9. VAD Placement
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Of nineteen responses, the number of PICCs placed annually ranged from 6 to 1000, with
an average of 272. Of seventeen responses, the number of MCs placed annually ranged from 0
to 500, with an average of 82. Survey results from the questions asking about rates of infection
and extravasation for VADs were tabulated incorrectly and are therefore not available for
analysis.
Knowledge and Beliefs (Figures 10 and 11)

Figure 10. VAD Use
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Figure 11. VAD Agreement
Comments
Several participants submitted comments in the section provided at the end of the survey.
The majority of the comments referred to their experience of using PICC lines as MCs when they
are not centrally placed. One respondent indicated that MCs are often considered a “default”
when a centrally placed PICC is not obtained. Another commented that “if a PICC becomes
dislodged, it may be salvaged as a MC”. Some mentioned that they do not use different MC
devices and that these catheters are referred to as “peripheral PICCs”. And finally, one
participant reported that their unit is having difficulty in obtaining agreement among providers to
use MCs due to lack of research.
Discussion
Findings
Demographics. The majority of respondents are Certified Neonatal Nurse Practitioners
or Registered Nurses certified in Neonatal Intensive Care Nursing and reported working in Level
3 NICUs located in urban areas.
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Procedure Guidelines, Protocols, and Training. Survey responses indicate that most
NICUs have a VAD Team and follow National Guidelines for VAD insertion and maintenance.
Interestingly, while most reported having a unit-specific PICC Protocol, the majority of
responses also indicated the absence of a MC protocol. More than half reported formal PICC
training, but only one quarter of surveys indicated formal training as a requirement for placing
MCs. In addition, while over half of the participants reported that they are required to complete
competencies on a regular basis for PICCs, only 2 participants reported a requirement to
complete MC competencies.
Participant Estimates of Successful VAD Placement and Usage. Participants
estimated personal success with VAD placement to be highest with PIV and PICC attempts, and
lowest with MC attempts. Although the answers varied greatly, all participants indicated more
PICCs are placed annually in their units, than MCs.
Knowledge and Beliefs. Respondents were able to correctly identify the definitions for
PICC and MC. Of the 13 participants that responded to the questions pertaining to their beliefs
about MC use, most indicated that no change is necessary, which suggests that they feel current
MC use in their unit is appropriate. However, the same participants also indicated that clinical
providers often disagree about MC use. In addition, the comments by participants point to a lack
of consistency in regard to MC use in the NICU.
Implications for Practice
In order to integrate high level clinical evidence into patient care, clinicians are
challenged to synthesize mass quantities of published data, and incorporate these changes into
daily practice. Furthermore, institutional and national guidelines currently in place may not be
evidence based, and some clinicians may be reluctant to practice differently if the evidence does
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not coincide with tradition or clinician experience. According to Black and Brennen (2011),
successful implementation of practice change depends upon the ability to translate knowledge
into practice, account for unit culture, manage change, encourage staff buy-in, incorporate a
multidisciplinary approach, and utilize peer champions.
The only currently available national guideline for MC use in the neonatal population is
NANN’s PICC Guidelines for Practice which currently lacks sufficient information for safe and
effective use of MCs. Neonatal nurses and Nurse Practitioners who rely on these guidelines for
MC use may appreciate the need to improve upon them by individually evaluating this document
using the AGREE II tool.
Multicenter, randomized control trials are needed to evaluate current MC practice in the
NICU, and the rates of infection and extravasation associated with their use. This data must be
disseminated in such a way that provides clinicians with the evidence necessary to incorporate
these changes into patient care on a daily basis.
Conclusion
The results of this small, online survey indicate that while some neonatal nurses and
Nurse Practitioners report the use of MC use in the NICU, few have MC-specific protocols in
place. In addition, few receive formal MC training and MC competencies are rarely required,
which may explain participant estimation of less success with MC placement. And finally,
survey responses and comments indicate a lack of consistency in MC use and some disagreement
among providers regarding appropriate use of this VAD.
Ongoing evaluation of current practice and incorporation of evidence based research into
guidelines and protocols is a requirement for the provision of high quality, cost efficient care.
MCs are not an appropriate VAD for NICU patients due to insufficient high level evidence
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demonstrating safety and efficacy; thus, the continued use of this VAD may be called into
question with regard to ethics, cost, and liability. In summary, institutions must establish
outcome data for MC use which is specific for neonates and infants, and incorporates current,
evidence based practice into policies, procedures, and guidelines.

27
Appendix A: Midline Catheter Literature Review
Table 1
Midline Catheter Literature Review: Background and Discussion
Author
(Year)

Lit
Type

Advantages

Disadvantages
Risk of extravasation
can be high, not
recommended for
dextrose solution >10%,
pH >5 and <9, most
common complication is
mechanical phlebitis
High rates of phlebitis
and thrombosis with
vesicant drugs

Not suitable for patients
with history of thrombosis,
hypercoagulopathy, or
compromised venous
circulation

MC may be used in a variety of
acute care setting where multiple
peripheral cannulas traditionally
have been used or as a
replacement for a PICC
or CVC.

Few studies investigating
MC outcomes

Use of a MC in place of a PIV
comes at no extra operational
costs to the hospital system, but
offers a significant gain in
positive outcomes.

MCs not evaluated

MCs are different from
PINCCs as they are shorter
IV catheters, typically
placed in the extremities
with the tip purposefully
meant to extend no further
than the axillary vein or the
inguinal fold.

MCs can be used both safely
and effectively to provide stable
IV access and to avoid many of
the complications typically
associated with central lines.

Alexandrou et al.
(2011)

Lit Review

Fewer PIVs,
Cost-effective,
Potential to avoid
infection, no XR
confirmation necessary

Anderson et al.
(2004)

Lit Review and
program
implementation
process

Colacchio et al.
(2012)

Retrospective
Observational
(PICC)

In comparison to PIVs,
fewer needle sticks,
lower rates of
infiltration and
phlebitis, increased
patient satisfaction,
savings in nursing time
and equipment costs

Comments

Recommendations
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Author
(Year)

Dawson (2002)

Lit
Type

Retrospective
chart review
(PIV) and
program
implementation
(MC)

Griffiths (2007)

Synopsis

Moran (1992)

Synopsis

Advantages
Fewer venipunctures
attempts; no mortality
or morbidity factors
associated with use; cost
savings due to less
nursing time, less
pharmacy cost, and
shorter length of stay;
less handeling and
longer periods of
uninterrupted sleep
which could result in
improved weight gain
and shorter length of
stay
Fewer PIVs, well
tolerated by patients,
may allow for earlier
discharge, XR
confirmation not
typically required, ease
of insertion, patient
comport, ideal for
patients with limited
venous access, cost
effective, acceptable for
analgesia infusion

Disadvantages

Comments

Recommendations

Only acceptable for
solutions safe for PIVs;
average dwell time of
6.3 days

MCs placed on admission
for all patients requiring 3+
days of IV therapy

Use of MCs to deliver fluids in
neonatal patients is appropriate

Not appropriate for
Dextrose >10% or
vesicants (such as
antibiotics), does not
accommodate >70
mL/min, gravity infusion
may not be possible,
mechanical phlebitis, not
applicable if venous
anatomy is
compromised, lack of
trained personnel
FDA discontinued the
use of Landmark
Aquavene catheters in
the 1990s for concerns
for hypersensitivity
reactions; mechanical
phlebitis only reported in
this study

Few studies available;
institutional policy will
dictate frequency of
flushing; nursing procedure
that requires medical order;
dwell time may be for the
duration of treatment rather
than a specified time scale

MCs are a reliable VAD
suitable for the safe delivery of
IV drugs and fluids for patients
who require medium to longterm therapy.

Factors to consider when
choosing a VAD –
gestational age, weight,
congenital anomalies,
cardiorespiratory
monitoring, sepsis, the
number and frequency of
caustic infusions, previous
history of venous access
devices, and the duration
required
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Author
(Year)

Rosenthal (2008)

Victor (1997)

Lit
Type

Advantages

Disadvantages

Synopsis

Better hemodilution
than PIVs; doesn’t
require suturing; shorter
hospital stay, improved
patient satisfaction

Commentary Re:
Lesser et al.
(1996)

Provides
developmentally
appropriate and less
stressful environment,
may decrease the risk of
iatrogenic complications
from PIV

Not appropriate for
isotonic drugs/solutions,
for infusion of
continuous vesicants or
irritants such as >10%
Dextrose, parenteral
nutrition, or for meds
with high or low pH
values like Vancomycin
(2.4) or Dilantin (12);
requires trained
personnel; associated
with insertion-related
phlebitis

Comments

Recommendations
MCs are an effective tool to
preserve a patient’s peripheral
access and offer a cost-effective
alternative to frequent IV site
rotations.

This study should be
replicated with a larger
sample size to validate the
results

MCs are a safe and effective
method for delivering IV therapy
for 1-2 weeks.
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Table 2
Midline Catheter Literature Review: Observational Studies
Author
(Year)

Goetz et al.
(1998)

Leick-Rude &
Haney (2006)

Lit
Type

Prospective
Observational

Prospective
Quality
Assurance

Advantages

Disadvantages

Comments

Recommendations

N=

Fewer PIV starts,
XR not required,
cost savings,
potential to
preserve veins in
patients with
limited access,
minimizes patient
transfer in some
institutions
Longer dwell
times and fewer
venipunctures
than PIVs; fewer
complications
than PICCs; safe
for antibiotics,
Insulin,
Prostaglandin, and
blood transfusion
products; may be
used for
antibiotics when
sepsis is proven
and PICC
discontinued

Potential for chemical
and mechanical
phlebitis, and
obstruction

Recommended for
dwell times > 7d

MCs can be used for
prolonged IV therapy and
are associated with
infection rates comparable
to PICC/CVL. MC is
superior to PIV for
patients with limited
access who need extended
IV therapy.

- 248 patients
- ages 23-98
years
- 334 MCs

Not appropriate for
vesicant chemotherapy,
parenteral nutrition,
>10% dextrose or 5%
protein, solutions or
meds with pHs <5 or
>9, or osmolality >500
mOsm/liter; 34%-49%
removal rate due to
infiltration, leaking, or
edema; not suitable for
Vasopressors; not
suitable to draw blood
samples

Catheter duration by
patient weight/
insertion site and
reasons for catheter
removal described in
detail; PICC and MCs
placed at time of
umbilical catheter
removal; care
practices aimed at
extending catheter
dwell time require
further investigation

MCs can be effectively
and safely used for
preterm and other highrisk neonates to provide
extended peripheral
vascular access while
avoiding many of the
complications associated
with central lines.

- N not
described
- 23-42 weeks
gestation
- 1,130 MCs
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Author
(Year)

Lit
Type

Lesser et al.
(1996)

Prospective
Observational

Mermel et al.
(1995)

Prospective
Observational

Wyckoff (1999)

Prospective
Observational

Advantages
PIVs lasted 3.1
+/-1.5 days
compared to 9.0
+/- 1.4 for MCs;
time and cost for
CVCs and MCs
are comparable
but with fewer
complications
Low risk for
infection, reduce
hospital and
patient cost, XR
not indicated
External jugular,
axillary, long and
short saphenous,
temporal, and
posterior auricular
veins are
appropriate sites
for consideration;
MC dwell times
have been
reported to be
almost 3x longer
than PIVs; XR not
typically required;
may enable DC
home for
completion of IV
therapy; decreased
skin
extravasation;
decreased risk of
infection, cost
efficient

Disadvantages

Comments

More prospective
studies are needed to
establish safety.

Recommendations

N=

MCs provide easy, safe,
and prolonged intravenous
access in low birth weight
infants.

- N not
described
- 25-34 weeks
gestation
- 9 MCs

MCs fill an important
niche in the care of acute
and chronically ill patients.

-130 patients
- age not
described
- 140 MCs

MCs appear to be a
valuable alternative to
PIVs in neonates requiring
long-term IV access.

- N not
described
- 25-46 weeks
gestation
- 143 MCs
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Table 3
Midline Catheter Literature Review: Policies and Procedures
Author
(Year)

Lit
Type

Advantages

Disadvantages
Infusate comparable to
recs for PIVs, average
dwell time in neonates is
6-10 days, approximately
50% of neonates MCs are
removed due to comps
with migration/infiltration
XR recommended if
difficulty with
advancement, pain or
discomfort, no blood
return, or if guidewire is
bent after removal

Frey & Pettit
(2010)

INS textbook

Potential sites in
neonates include
antecubital, leg, and
scalp

INS (1997)

Position Paper

In neonates,
antecubital, external
jugular, axillary, long
and short saphenous,
temporal, and
posterior auricular
veins may be
considered

Comments

Recommendations

More studies are needed

No medical device is
without risk, VAD
assessment should lead to
choosing the least
invasive device

Institutions must establish
outcome data on their specific
patient populations for each
device and establish and revise
policies and procedures based on
the outcome data.
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Author
(Year)

INS (2011)

Lit
Type

Standards of
Practice

JBI Best
Practice(2008)

EBP Info Sheet

NANN (2007)

Guidelines

Advantages

Disadvantages

Appropriate for
therapies anticipated
to last 1-4 weeks;
may be used for
hydration, IV
solutions, pain
medications, and
some antibiotics;
catheter tip does not
enter central
vasculature; available
as single or double
lumen, polyurethane
or silicone, and in
gauge sizes of 22-24;
additional insertion
sites (leg,scalp) may
be considered for
neonates

Reported dwell times for
neonates is 6-10 days; not
appropriate for vesicant
therapy, parenteral
nutrition, infusates with
pH<5 or > 9, and infused
with osmolality >600
mOsm/L

Dwell times reported
to be between 6-10
days and up to four
times as long as PIVs;
fewer PIV restarts and
longer lifespan; cost
of MC equivalent to
3-4 days of PIV

Not appropriate for
dextrose >10%, parenteral
nutrition, Ampicillin,
Cefotaxime, Sodium
Bicarbonate, and
Phenobarbital, or
osmolality
>600mOsm/kg, not
appropriate for vesicants
such as Amphoteracin B,
Vasopressin, resuscitation
meds, Dopamine, or
Calcium

Comments
Tip location at or below
the axillary line

No data exist to support
dwell time limits

Recommendations
Indications and protocols for
VADs shall be established in
organizational policies,
procedures, and/or practice
guidelines and according to
manufacturers’ directions for use.

MCs appear to be associated with
lower rates of phlebitis and
infection than short peripheral
catheters and cost less than
central venous catheters.
MCs offer an alternative for those
infants who do not require a
PICC, but who need several days
of IV therapy.

34
Appendix B: AGREE II Author Score Sheet of NANN PICC Guidelines for Practice

Domain

Item

AGREE II Rating
1
Strongly
Disagree

Scope and
purpose

Stakeholder
involvement

Rigor of
development

2

3

1.

The overall objective(s) of the guideline is (are) specifically described.

2.

The health question(s) covered by the guideline is (are) specifically described.

3.

The population (patients, public, etc.) to whom the guideline is meant to apply is
specifically described.

4.

The guideline development group includes individuals from all the relevant
professional groups.

5.

The views and preferences of the target population (patients, public, etc.) have
been sought.

6.

The target users of the guideline are clearly defined.

7.

Systematic methods were used to search for evidence.

8.

The criteria for selecting the evidence are clearly described.

X

9.

The strengths and limitations of the body of evidence are clearly described.

X

10. The methods for formulating the recommendations are clearly described.

4

5

X
X
X
X
X
X

X
X

12. There is an explicit link between the recommendations and the supporting
evidence.

X

13. The guideline has been externally reviewed by experts prior to its publication.

Clarity of

15. The recommendations are specific and unambiguous.

Strongly
Agree

X

11. The health benefits, side effects and risks have been considered in formulating
the recommendations.

14. A procedure for updating the guideline is provided.

7

6

X
X
X
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Domain

Item

AGREE II Rating
1
Strongly
Disagree

2

3

4

5

6

7
Strongly
Agree

presentation
16. The different options for management of the condition or health issue are
clearly presented.

X

17. Key recommendations are easily identifiable.
Applicability

X

18. The guideline describes facilitators and barriers to its application.

X

19. The guideline provides advice and/or tools on how the recommendations can
be put into practice.

Editorial
independence

X

20. The potential resource implications of applying the recommendations have
been considered.

X

21. The guideline presents monitoring and/ or auditing criteria.

X

22. The views of the funding body have not influenced the content of the guideline.

X

23. Competing interests of guideline development group members have been
recorded and addressed.

X

Overall
Guideline
Assessment

1.

Rate the overall quality of this guideline.

Overall
Guideline
Assessment

2. I would recommend this guideline for use.

X
Yes

Yes, with modifications

X

No
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Appendix E: Survey Objectives
MC Use in the NICU: Current Practice Inquiry
1. Are MCs being used in NICUs across the US? And if so, where and how frequently?
2. Are the MCs being used, truly MCs by definition?
3. What level of nurses are placing MCs?
4. What type of training is required for nursing and NNPs to place MCs?
5. What are individual nurse and NNP success rates for MC and PICC insertions?
6. Do NICUs follow NANN and/or institutional protocols for PICCs and MCs?
7. What are the rates of infection, extravasation, and phlebitis associated with VADs in
NICUs?
8. What are the individual and institutional preferences for the use of MCs in NICU
patients?
9. Do nurses and NNPs have an understanding of the available literature and
recommendations regarding evidence based practice for MC use in the NICU?
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Appendix F: National Association of Neonatal Nurses Online Survey
Midline Catheter Use in the Newborn Intensive Care Unit: Current Practice Inquiry
Q1 Dear National Association of Neonatal Nurses (NANN) and National Association of
Neonatal Nurse Practitioner (NANNP) Members: My name is Tricia Romesberg. I am a
doctoral student conducting a survey for my Doctor of Nursing Practice (DNP) Project at the
University of North Florida (UNF) in Jacksonville, Florida. I am requesting your assistance to
help me understand midline catheter use in the Newborn Intensive Care Unit (NICU). Your
participation is important because survey results could add to the body of knowledge regarding
current vascular access device practices for NICU patients. To be included in the sample for
the survey, you must be a NANN and/or NANNP member. This survey will take approximately
10 minutes to complete. Qualtrics, the survey software, is designed to insure that all data will be
submitted anonymously. I will not have access to your identity at any time. To insure further
data security, data submitted will be stored on a locked and secure computer. Your participation
is voluntary. While there are no anticipated risks involved in completing and submitting the
survey, if you start the survey and then decide not to complete it, you may simply log out of
Qualtrics and no data will be submitted or saved. Participation and completion of the survey will
acknowledge your consent. Participation is limited to those who are at least 18 years of
age. The survey will be available for participation during a one month period between May 2014
and September 2014. Please print a copy of this document for your records. This study has
received the approval of Institutional Review Board at the University of North Florida, IRB #
558281, which functions to insure the protection of the rights of human participants. If you have
any questions about being a research participant, you may contact the UNF Institutional Review
Board at
or via email at irb@unf.edu. Approval to post this survey on MyNANN
You may contact me via email at
was granted by the NANN Research Institute.
or by phone at
I would like to thank you in
advance for your participation in this survey. Respectfully, Tricia Romesberg, MSN, ARNP
University of North Florida DNP Student Dr. Carol Ledbetter, PhD, APRN-BC, FAAN
University of North Florida DNP Project Chair
By
clicking the “next” button, you agree to participate in this survey.
Q2 What type of geographic area do you work in?
 rural
 urban
 metropolitan
Q3 If you work in a Newborn Intensive Care Unit, what is the level of acuity?
 Level 1
 Level 2
 Level 3
 Other: ____________________
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Q4 How many total months and years have you worked in the Newborn Intensive Care Unit as a
nurse and/or Nurse Practitioner?
 months
 years
Q5 Do you care for infants in a setting other than the Newborn Intensive Care Unit?:
 No
 Yes - please describe: ____________________
Q6 What is your level of education specific to caring for neonates and infants? Check all that
apply:
 registered nurse
 Registered Nurse Certified (RNC) for Neonatal Intensive Care Nursing
 Certified Neonatal Nurse Practitioner
 Other: ____________________
Q7 Have you been trained to place Peripherally Inserted Central Catheters? If yes, check all that
apply:
 At a formal training seminar
 As a procedural requirement for your job
 Informally by another nurse or nurse practitioner
 Self taught or no training
 Other: ____________________
Q8 Are you required by your unit or institution to complete competencies on a regular basis to
place Peripherally Inserted Central Catheters?
 Yes
 No
Answer If Are you required by your unit or institution to complete competencies on a regular
basis to place Peripherally Inserted Central Catheters? Yes Is Selected
Q9 If yes, how often are Peripherally Inserted Central Catheter competencies required? Every:
______ months
______ years
Q10 Have you been trained to place Midline Catheters? If yes, check all that apply:
 At a formal training seminar
 As a procedural requirement for you job
 Informally by another nurse or nurse practitioner
 Self taught or no training
 Other: ____________________
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Q11 Are you required by your unit or institution to complete competencies on a regular basis to
place Midline Catheters?
 Yes
 No
Answer If Are you required by your unit or institution to complete competencies on a regular
basis to place Midline Catheters? Yes Is Selected
Q12 If yes, how often are Midline Catheter competencies required? Every:
______ months
______ years
Q13 Please answer yes or no:
Yes

No

Does your unit have a
vascular access or
Peripherally Inserted Central
Catheter Team?





Does your unit adhere to
NANN's 2007 Peripherally
Inserted Central Catheter
Guidelines for Practice?





Does your unit have a unitspecific Peripherally Inserted
Central Catheter Protocol for
neonates and infants?





Does your unit have a unitspecific Midline Catheter
Protocol for neonates and
infants?





Q14 At your current place of employment, please estimate percentages of the following:

Peripheral IVs
Midline Catheters
Peripherally Inserted
Central Catheters

Click to write Column 1

Click to write Column 2

Click to write Column 3

Infection

Extravasation

Phlebitis
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Q15 In your best estimate, how many Peripherally Inserted Central Catheters are placed annually
in your unit?
 ____________________
 How many are placed by you? ____________________
Q16 In your best estimate, how many Midline Catheters are placed annually in your unit?
 ____________________
 How many are placed by you? ____________________
Q17 Please rate your personal success in achieving insertion and proper placement of the
following vascular access devices:
Peripheral IV

Midline Catheter

Peripherally Inserted
Central Catheter

Never







Rarely







Sometimes







Often







All of the Time







Q18 Based on your clinical experience with Midline Catheters in the unit you currently work in,
it is your opinion that Midline Catheters should be used:______
Q19 Disagreement about Midline Catheter use among the clinical providers in you unit occurs:
______
Q20 The definition of a Peripherally Inserted Central Catheter is: "a device inserted into a
peripheral vein and threaded into the central venous circulation."
 True
 False
Q21 The definition of a Midline Catheter is: "a peripheral vascular access device with the tip
terminating in the basilic, cephalic, or brachial vein."
 True
 False
Q22 Midline Catheter use in neonates and infants is supported by high level evidence such as
systematic reviews and/or randomized clinical trials.
 True
 False
Q23 Comments on your experiences with Midline Catheter use in neonates and infants?
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